Target-based discovery of a broad-spectrum flukicide.


Journal

Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374

Informations de publication

Date de publication:
07 May 2024
Historique:
received: 28 11 2023
accepted: 28 03 2024
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 7 5 2024
Statut: aheadofprint

Résumé

Diseases caused by parasitic flatworms impart a considerable healthcare burden worldwide. Many of these diseases-for example, the parasitic blood fluke infection schistosomiasis-are treated with the drug praziquantel (PZQ). However, PZQ is ineffective against disease caused by liver flukes from the genus Fasciola because of a single amino acid change within the target of PZQ, a transient receptor potential ion channel in the melastatin family (TRPM

Identifiants

pubmed: 38714890
doi: 10.1038/s41594-024-01298-3
pii: 10.1038/s41594-024-01298-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Andrews, P. et al. Praziquantel. Med. Res. Rev. 3, 147–200 (1983).
doi: 10.1002/med.2610030204 pubmed: 6408323
Waechtler, A. et al. Praziquantel—50 years of research. ChemMedChem 18, e202300154 (2023).
doi: 10.1002/cmdc.202300154 pubmed: 37009677
Spangenberg, T. Alternatives to praziquantel for the prevention and control of schistosomiasis. ACS Infect. Dis. 7, 939–942 (2021).
doi: 10.1021/acsinfecdis.0c00542 pubmed: 32819092
Farid, Z. et al. Praziquantel and Fasciola hepatica infection. Trans. R. Soc. Trop. Med. Hyg. 83, 813 (1989).
doi: 10.1016/0035-9203(89)90339-8 pubmed: 2617651
Arafa, W. M. et al. Comparing an in vivo egg reduction test and in vitro egg hatching assay for different anthelmintics against Fasciola species, in cattle. Vet. Parasitol. 214, 152–158 (2015).
doi: 10.1016/j.vetpar.2015.09.023 pubmed: 26455573
Mehmood, K. et al. A review on epidemiology, global prevalence and economical losses of fasciolosis in ruminants. Micro. Pathog. 109, 253–262 (2017).
doi: 10.1016/j.micpath.2017.06.006
Beesley, N. J. et al. A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance. PLoS Pathog. 19, e1011081 (2023).
doi: 10.1371/journal.ppat.1011081 pubmed: 36701396 pmcid: 9904461
Fairweather, I. et al. Drug resistance in liver flukes. Int J. Parasitol. Drugs Drug Resist. 12, 39–59 (2020).
doi: 10.1016/j.ijpddr.2019.11.003 pubmed: 32179499 pmcid: 7078123
Kelley, J. M. et al. Current threat of triclabendazole resistance in Fasciola hepatica. Trends Parasitol. 32, 458–469 (2016).
doi: 10.1016/j.pt.2016.03.002 pubmed: 27049013
McVeigh, P. et al. Reasons to be nervous about flukicide discovery. Trends Parasitol. 34, 184–196 (2018).
doi: 10.1016/j.pt.2017.11.010 pubmed: 29269027
Selzer, P. M. & Epe, C. Antiparasitics in animal health: quo vadis? Trends Parasitol. 37, 77–89 (2021).
doi: 10.1016/j.pt.2020.09.004 pubmed: 33039282
Park, S. K. et al. The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel. J. Biol. Chem. 294, 18873–18880 (2019).
doi: 10.1074/jbc.AC119.011093 pubmed: 31653697 pmcid: 6901322
Park, S. K. & Marchant, J. S. The journey to discovering a flatworm target of praziquantel: a long TRP. Trends Parasitol. 36, 182–194 (2020).
doi: 10.1016/j.pt.2019.11.002 pubmed: 31787521
Harder, A. Activation of transient receptor potential channel Sm.(Schistosoma mansoni)TRPM
doi: 10.1007/s00436-020-06763-8 pubmed: 32607709 pmcid: 7366562
Park, S. K. et al. Mechanism of praziquantel action at a parasitic flatworm ion channel. Sci. Transl. Med. 13, eabj5832 (2021).
doi: 10.1126/scitranslmed.abj5832 pubmed: 34936384 pmcid: 8855674
Rohr, C. M. et al. Natural variation in the binding pocket of a parasitic flatworm TRPM channel resolves the basis for praziquantel sensitivity. Proc. Natl Acad. Sci. USA 120, e2217732120 (2023).
doi: 10.1073/pnas.2217732120 pubmed: 36574686
Chulkov, E. G. et al. Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel. PLoS Negl. Trop. Dis. 15, e0009898 (2021).
doi: 10.1371/journal.pntd.0009898 pubmed: 34731172 pmcid: 8565742
Fairweather, I. & Boray, J. C. Fasciolicides: efficacy, actions, resistance and its management. Vet. J. 158, 81–112 (1999).
doi: 10.1053/tvjl.1999.0377 pubmed: 10489266
Setshedi, K. J. et al. 2-Aroyl quinazolinone: synthesis and in vitro anti-parasitic activity. Chem. Biol. Drug Des. 102, 763–772 (2023).
doi: 10.1111/cbdd.14284 pubmed: 37353860
Ashraf-Uz-Zaman, M. et al. Quinazolinone compounds have potent antiviral activity against Zika and dengue virus. J. Med. Chem. 66, 10746–10760 (2023).
doi: 10.1021/acs.jmedchem.3c00924 pubmed: 37506506
Pan, M. et al. Asymmetric synthesis of N–N axially chiral compounds by phase-transfer-catalyzed alkylations. Org. Lett. 24, 374–378 (2022).
doi: 10.1021/acs.orglett.1c04028 pubmed: 34928616
Lin, W. et al. Asymmetric synthesis of N–N axially chiral compounds via organocatalytic atroposelective N-acylation. Chem. Sci. 13, 141–148 (2022).
doi: 10.1039/D1SC05360D
Yin, Y. & Lee, S. Y. Current view of ligand and lipid recognition by the menthol receptor TRPM8. Trends Biochem. Sci. 45, 806–819 (2020).
doi: 10.1016/j.tibs.2020.05.008 pubmed: 32532587 pmcid: 9284947
Chulkov, E. G., Rohr, C. M. & Marchant, J. S. Praziquantel activates a native cation current in Schistosoma mansoni. Front. Parasitol. 2, 1285177 (2023).
doi: 10.3389/fpara.2023.1285177
Karnovsky, M. J. A formaldehyde–glutaraldehyde fixative of high osmolality for use in electron microscopy. J. Cell Biol. 27, 137–138A (1965).
Glauert, A. M. & Lewis, P. R. Biological Specimen Preparation for Transmission Electron Microscopy (Princeton Univ. Press, 1998).

Auteurs

Daniel J Sprague (DJ)

Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
Program in Chemical Biology, Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA.

Sang-Kyu Park (SK)

Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.

Svenja Gramberg (S)

BFS, Institute of Parasitology, Justus Liebig University Giessen, Giessen, Germany.

Lisa Bauer (L)

BFS, Institute of Parasitology, Justus Liebig University Giessen, Giessen, Germany.

Claudia M Rohr (CM)

Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.

Evgeny G Chulkov (EG)

Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.

Emery Smith (E)

The Herbert Wertheim UF Scripps Institute Molecular Screening Center, Department of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA.

Louis Scampavia (L)

The Herbert Wertheim UF Scripps Institute Molecular Screening Center, Department of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA.

Timothy P Spicer (TP)

The Herbert Wertheim UF Scripps Institute Molecular Screening Center, Department of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA.

Simone Haeberlein (S)

BFS, Institute of Parasitology, Justus Liebig University Giessen, Giessen, Germany.

Jonathan S Marchant (JS)

Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA. JMarchant@mcw.edu.

Classifications MeSH